Yohimbine
Yohimbine HCl · Yohimbe · Corynine · Aphrodine · Quebrachine
Last updated
At a glance
Overview
Why Yohimbine Earned Its Place in the Cutting Toolkit#
Yohimbine is the go-to tool for the last mile of a cut — the stubborn lower-ab, hip, and thigh fat that refuses to budge even when diet and cardio are dialed in. It works by blocking α2-adrenergic receptors, which are densely packed in exactly those "problem" depots. Under fasted, sympathetic conditions, that α2 blockade removes the brake on lipolysis and lets catecholamines finish the job.
The community has converged on a tight protocol for a reason: ~0.2 mg/kg taken 20–30 minutes before fasted cardio, kept away from any food or insulin spike that would shut the effect down. Run correctly during the final 4–8 weeks of prep, it's one of the few non-hormonal supplements with published human data showing meaningful body-fat reduction in already-lean athletes.
"After 21 days, test group athletes experienced a significant decrease in body fat percentage (from 9.3% ±1.1% to 7.1% ±2.2%), while no changes were observed in the placebo group." — Ostojic, Research in Sports Medicine (2006)
That said, yohimbine is not a casual "fat burner." It's a sympathomimetic with real cardiovascular and anxiogenic effects, CYP2D6-driven variability that makes some people hyper-responders, and a narrow window of usefulness (below ~12% body fat in men, ~20% in women). Used outside that window, or eaten into with a pre-cardio shake, it does almost nothing.
In this guide we'll cover the full yohimbine dosage ladder (beginner test dose through advanced pre-contest protocols), the core yohimbine benefits backed by published data, the yohimbine side effects and hard contraindications worth respecting, how to build a proper yohimbine stack with caffeine and β-agonists for stubborn-fat work, and how it compares to alternatives like clenbuterol, albuterol, and plain old fasted cardio.
How Yohimbine works
Yohimbine is an indole alkaloid from the bark of Pausinystalia johimbe that works almost entirely through one clean pharmacological lever: selective antagonism of α2-adrenergic receptors. At sensible doses it's roughly 30–100× more selective for α2 over α1, which is what separates it from a dirty stimulant and gives it a specific, useful role in stubborn-fat protocols.
Alpha-2 Blockade and Stubborn-Fat Lipolysis#
This is the mechanism physique-focused users actually care about. Subcutaneous fat in the "stubborn" depots — lower abdomen and glute/hip in men, hip and outer thigh in women — has a disproportionately high ratio of α2 to β-adrenergic receptors. When sympathetic drive rises (fasted cardio, cold exposure, caffeine), circulating catecholamines hit β-receptors to activate hormone-sensitive lipase via cAMP/PKA and hit α2-receptors, which are Gi-coupled and suppress cAMP — effectively putting a brake on lipolysis in exactly the fat you're trying to shift. Yohimbine removes that brake.
"Oral yohimbine (0.2 mg/kg) led to a significant increase in plasma glycerol and free fatty acid levels during exercise, indicating enhanced lipolysis through alpha 2-adrenoceptor blockade." — Galitzky J. et al. European Journal of Clinical Investigation, 1988
Practically: this is why the protocol is fasted and why the dose is pre-cardio. Without elevated catecholamines, there's nothing for α2 to brake, and yohimbine does very little on its own.
Insulin Is the Off-Switch#
Insulin is one of the most powerful anti-lipolytic signals in the body, and it restores α2 tone (and then some) regardless of what yohimbine is doing at the receptor. Even a whey shake or a splash of milk in pre-workout coffee generates enough of an insulin response to blunt the entire mechanism. This is non-negotiable — the evidence-based pre-cardio protocol only works in a genuinely fasted state (water, electrolytes, black coffee). Eat, and you've wasted the dose.
Central Noradrenergic Drive#
Presynaptic α2 autoreceptors also function as a negative feedback loop on norepinephrine release in the CNS and sympathetic nerve terminals. Blocking them increases NE output — which is where the stimulant-like feel, the bump in systolic BP, the appetite blunting, and the anxiogenic edge all come from.
"Yohimbine induced panic attacks in 72% of panic disorder patients but only 13% of healthy controls, supporting its use as a pharmacological probe of noradrenergic function in anxiety disorders." — Charney DS, Heninger GR, Breier A. Archives of General Psychiatry, 1984
For a healthy user this translates to sharper focus and a useful kick into fasted cardio. For anyone with an anxiety, panic, or PTSD history, this same mechanism is why the compound is a hard pass — it's literally used as a research tool to provoke panic.
CYP2D6 Metabolism and Why Everyone Responds Differently#
Yohimbine is metabolized almost entirely by hepatic CYP2D6, and CYP2D6 expression is genetically bimodal. Poor metabolizers get dramatically higher plasma exposure from the same oral dose than extensive metabolizers — which is why two lifters at the same bodyweight can have completely different experiences at 10 mg.
"Oral yohimbine kinetics and exposure varied strikingly, with area under the curve values ranging from 52 to 626 ng·hour·mL−1, mostly explained by genetic differences in CYP2D6 metabolism." — Le Corre P. et al. British Journal of Clinical Pharmacology, 1999
That's a >10× range in exposure from identical dosing. This is the mechanistic reason every protocol starts with a 2.5–5 mg test dose: if that produces a racing heart and dread-level anxiety, you're a poor metabolizer and need to stay at the low end. If you barely feel it, you can titrate up toward 0.2 mg/kg confidently.
Peripheral Vasomotor and Erectile Effects#
α2 antagonism in the peripheral nervous system also enhances cholinergic and noradrenergic outflow to genital tissue, which is why yohimbine was a first-line oral ED drug before PDE5 inhibitors existed. The effect is modest compared to tadalafil or sildenafil and more relevant when the underlying issue is psychogenic or noradrenergically mediated than when it's vascular. For on-cycle users struggling with libido despite decent E2 management, it's occasionally worth a try — but it's a secondary use, not a reason to run the compound.
Protocol
| Level | Dose | Frequency | Notes |
|---|---|---|---|
| Low | 2.5–5 mg/kg | Once daily | Documented entry-level range |
| Mid | 10–15 mg/kg | Once daily | Most commonly studied range |
| High | 15–25 mg/kg | Once daily | Dosed 20–30 min before fasted cardio. Do not dose in the evening — short half-life but enough residual noradrenergic drive to wreck sleep. Advanced users may split into AM + pre-training, both fasted. |
Cycle length & outcomes
Documented cycle
4–12 weeks
Plateau after
8 wks
Cycle Notes#
Yohimbine doesn't cycle like a hormonal compound — there's no HPTA suppression, no receptor downregulation worth tapering around, and no PCT. What dictates cycle length is when it's actually useful: the back half of a cut, once you're lean enough that α2-dense stubborn-fat depots are the bottleneck. Running it at 15%+ body fat is wasted; save it for the last-mile grind.
Cycle Length by Goal#
| Goal | Cycle Length | Daily Dose | Timing |
|---|---|---|---|
| First-time assessment | 3–5 days | 2.5–5 mg | Pre-fasted cardio |
| Stubborn-fat cut (standard) | 4–8 weeks | 0.2 mg/kg (10–15 mg) | 20–30 min pre-fasted cardio |
| Pre-contest / photoshoot peak | 2–3 weeks | 0.3–0.4 mg/kg split AM + pre-training | Both fasted |
| Alpha-beta stack (with clen/albuterol) | 4–6 weeks | 10–15 mg | Pre-fasted cardio only |
| Psychogenic ED / on-cycle libido | As needed | 5.4 mg TID or 10 mg × 1 | ~1 hr pre-activity |
Most physique-focused users run 4–8 weeks during the final third of a cut and drop it off-season. Twelve weeks is the practical ceiling, not because of tolerance but because by then your cut should be over.
Onset Timing#
The lipolytic effect is immediate on a per-session basis — dose 20–30 min out, train for 45–60 min, and the drug is mostly cleared by the time you break fast. You are not waiting weeks for yohimbine to "kick in" the way you would with a peptide or AAS.
What does take time to show up is measurable fat loss in stubborn depots, which is the whole point of running it. Expect roughly 3–4 weeks before lower-ab or hip/thigh fat visibly responds, consistent with the 21-day Ostojic data:
"After 21 days, test group athletes experienced a significant decrease in body fat percentage (from 9.3% ±1.1% to 7.1% ±2.2%), while no changes were observed in the placebo group." — Ostojic, Research in Sports Medicine, 2006
Test Dose First — CYP2D6 Variability Is Real#
Before committing to a protocol, run 2.5–5 mg fasted on a rest day and watch your HR, BP, and anxiety response for 2 hours. Oral exposure varies ~12-fold between individuals due to CYP2D6 polymorphism:
"Oral yohimbine kinetics and exposure varied strikingly, with area under the curve values ranging from 52 to 626 ng·hour·mL⁻¹, mostly explained by genetic differences in CYP2D6 metabolism." — Le Corre et al., Br J Clin Pharmacol, 1999
If 5 mg produces a racing heart, tremor, or a panic-adjacent feel, you're a poor metabolizer — cap yourself at 5–7.5 mg and do not chase the 0.2 mg/kg heuristic. If 5 mg feels like nothing, scale up to weight-based dosing.
Loading and Tapering#
No loading phase. α2-antagonism is a same-session pharmacological effect — lipolysis is elevated within an hour of the first dose:
"Oral yohimbine (0.2 mg/kg) led to a significant increase in plasma glycerol and free fatty acid levels during exercise, indicating enhanced lipolysis through alpha 2-adrenoceptor blockade." — Galitzky et al., Eur J Clin Invest, 1988
No taper required. Stop when you're done cutting. There's no rebound, no withdrawal, no hormonal aftermath. If you've been running it alongside clen, taper the β2-agonist per its own protocol — yohimbine just gets dropped.
Fasted Means Fasted#
This is the single most abused point in community protocols. Insulin is a dominant anti-lipolytic signal, and even a protein shake or a splash of milk in coffee will blunt the effect. On dosing days:
- Water, black coffee, plain tea, electrolytes only
- No BCAAs, no whey, no carbs, no creamer
- Hold food for at least 60 min post-cardio
- If you train later in the morning and can't do it truly fasted, yohimbine is probably the wrong tool — use caffeine + training and save yohimbine for a proper fasted session
Monitoring Cadence#
No hormonal bloodwork is needed for yohimbine itself. What to watch:
| Check | When | Threshold to back off |
|---|---|---|
| Resting BP | Baseline, day 3–5, weekly | >140/90 sustained |
| Resting HR | Baseline, daily first week | >90 at rest, sustained |
| Sleep quality | Ongoing | Any disruption → move dose earlier or reduce |
| Anxiety / mood | Ongoing | Escalating anxiety → stop |
If you're already on-cycle with AAS and running bloodwork for lipids, hematocrit, and liver values, yohimbine doesn't change that cadence. It doesn't move those markers.
Timing Within the Day#
Dose once in the AM fasted, or for advanced users on a peaking phase, split AM + pre-training with both doses fasted. The half-life is short (~36 min) but enough residual noradrenergic drive exists to wreck sleep — never dose after ~2 PM. If your training is evening-only, yohimbine is a poor fit for that schedule; use it on AM cardio days instead and run a different pre-workout in the evening.
Dialed in correctly — 0.2 mg/kg, 20–30 min pre-fasted cardio, 4–8 weeks deep into a cut, no food until after the session — yohimbine does exactly what it's advertised to do on exactly the fat you're trying to shift. Outside that window, it's a stimulant with side effects and not much upside.
Body Transformation Preview
Lean Mass Gain
0.0 lbs
0.0–0.0 lbs range
Fat Loss
2.7 lbs
2.0–3.4 lbs range
Fat Loss by Week
Risks & mistakes
Common (most users)#
- Jitters, racing heart, mild anxiety — the hallmark sympathomimetic signature. Usually dose-dependent. Drop to 2.5–5 mg, skip stacking with pre-workout caffeine, and reassess. If you're already at 200 mg caffeine pre-cardio, the yohimbine dose that "works" is lower than you think.
- Elevated resting HR and blood pressure — systolic typically climbs 10–20 mmHg at training doses. Check cuff BP in the first week. If resting sits above 140/90, pull the dose back.
- Sweating, flushing, mild tremor — expected α2-blockade effects, not a problem. Hydrate, add electrolytes (sodium especially), ride it out.
- Insomnia if dosed late — half-life is short but residual noradrenergic drive is not. Dose AM only, pre-fasted cardio. No yohimbine after ~noon.
- Nausea or GI upset — take with a small amount of water only (no food — insulin kills the effect). If persistent, split the dose or drop it.
- Paresthesia ("pins and needles") — common on first exposure, benign, resolves as you acclimate or drop dose.
Uncommon (dose-dependent or individual)#
- Panic-level anxiety at "normal" doses — strong hint you're a CYP2D6 poor metabolizer. Exposure can be 10× higher than average at the same oral dose.
"Oral yohimbine kinetics and exposure varied strikingly, with area under the curve values ranging from 52 to 626 ng·hour·mL⁻¹, mostly explained by genetic differences in CYP2D6 metabolism." — Le Corre et al., 1999, Br J Clin Pharmacol
Always do a 2.5–5 mg test dose before committing to 0.2 mg/kg. If a 5 mg test feels like 20 mg should, you're a poor metabolizer — cap your ceiling at 5–7.5 mg.
- Hypertensive response on the alpha-beta stack — yohimbine + clen/albuterol + caffeine is aggressive. Monitor BP and resting HR daily. If HR sits >100 at rest or BP climbs past 150/95, drop one leg of the stack.
- Headache, dizziness on standing — usually dehydration plus sympathetic overshoot. Electrolytes and a lower dose fix it.
- Appetite suppression crossing into under-eating — fine during prep, a problem if it's cutting into protein intake. Track, don't eyeball.
- Mood irritability / edge — more common in weeks 3+ of a hard cut when baseline tolerance for stimulants is already frayed. Cycle off for a week.
Rare but serious#
- Full panic attack — yohimbine is literally a research tool for inducing panic in anxiety-disorder studies:
"Yohimbine induced panic attacks in 72% of panic disorder patients but only 13% of healthy controls, supporting its use as a pharmacological probe of noradrenergic function in anxiety disorders." — Charney et al., 1984, Arch Gen Psychiatry
If you've ever had a panic attack, yohimbine will almost certainly give you another. Stop immediately.
- Arrhythmia / palpitations that don't settle — stop the compound and get an ECG. Don't push through.
- Priapism — rare, but more likely if stacking with a PDE5 inhibitor. An erection lasting >4 hours is an ER trip.
- Hypertensive crisis — essentially only seen in combination with MAOIs, TCAs, or other strongly noradrenergic drugs. Mechanistically predictable, medically serious.
- Label inaccuracy injury — "yohimbe bark" products are notoriously erratic:
"Most yohimbe supplements contained pharmaceutical dosages of yohimbine, with actual content ranging from 0.1 to 12.1 mg per serving; some brands were underdosed or contained none at all." — Cohen et al., 2016, Drug Test Anal
Buy standardized yohimbine HCl from a reputable bodybuilding supplement brand. Skip the "yohimbe bark 500 mg" capsules.
Hard contraindications#
- Untreated hypertension, known CAD, or any arrhythmia history — do not run yohimbine.
- Panic disorder, generalized anxiety, PTSD — do not run yohimbine. It is the probe drug for noradrenergic anxiety.
- MAOIs or tricyclic antidepressants — risk of hypertensive crisis. Absolute no.
- Pregnancy — yohimbine is uterotonic and sympathomimetic. Absolute no.
- Significant renal or hepatic impairment — exposure becomes unpredictable; not worth the risk.
- Stacking with nitrates or very heavy PDE5i dosing — priapism and hypotension/hypertension swings.
- Evening dosing — not a safety contraindication, but a protocol one: you will not sleep.
Gender and cycle considerations#
Women tolerate weight-scaled dosing (~0.2 mg/kg) well and arguably get more out of yohimbine than men do — female lower-body fat depots (hip, thigh, glute) are especially α2-dense, which is exactly where the stubborn fat sits when cutting into the upper teens of body fat. No virilization risk, no hormonal impact. Pregnancy is an absolute contraindication; do not use while pregnant or attempting to conceive.
No PCT required. Yohimbine has zero HPTA impact, no effect on lipids, and no hormonal axis to recover. You can start and stop it freely — typical runs are 4–12 weeks during the back half of a cut, dropped once lean enough that you don't need it.
Stack & combine
Multipliers applied when these compounds run together. Values > 1 indicate a bonus on that axis. Tap a partner to expand the mechanism.
| Partner | Type | Lean | Fat loss | Recovery |
|---|---|---|---|---|
| synergistic | ×1.00 | ×1.22 | ×1.05 | |
| synergistic | ×1.00 | ×1.20 | ×1.00 | |
| synergistic | ×1.00 | ×1.17 | ×1.00 |
FAQ — Yohimbine
Research & citations
5 studies cited on this page.
Conclusion
Yohimbine carves out a clear lane for physique-focused users chasing stubborn fat loss — but proper dosing and synergy are what separate clean results from wasted effort (or side effects).
Key takeaways:
- Effective dose: 0.2 mg/kg orally (~10–15 mg for an 80 kg user) taken 20–30 min pre-fasted cardio
- Timing matters: Always run fasted, as insulin blunts the α2-blocking lipolytic effect
- Cycle length: 4–8 weeks during late-stage cutting; no PCT or shutdown concerns
- Stacking: Pairs well with caffeine (200 mg) for additive kick; advanced users may stack with clenbuterol/albuterol for aggressive stubborn-fat targeting
- Route: Oral yohimbine HCl beats bark extract for consistent dosing — avoid unstandardized supplements (Cohen et al., 2016)
- Watch outs: Anxiety, BP, and HR spike at higher or mistimed doses; start low (2.5–5 mg) if new
Yohimbine is not a magic pill — but when run correctly, it reliably unlocks fat-loss from stubborn areas and finishes a cut strong. If you respect the protocol, it earns its keep.